查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1481283

军团菌测试市场 - 按测试类型、应用、最终用途 - 全球预测，2024 年 - 2032 年

Legionella Testing Market - By Test Type, Application, End-use - Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 201 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在监管机构执行日益严格的水检测法规的推动下，全球军团菌检测市场规模在 2024 年至 2032 年间将实现 8.6% 的复合年增长率。随着公众健康和安全问题的显着增加，世界各地的当局正在对水系统中的军团菌检测实施严格的标准。

例如，2024 年，美国总务管理局 (GSA) 宣布将对众多联邦建筑进行全面的水质测试，以优先考虑居住者和游客的健康和安全。这种积极主动的方法有助于建筑经理保持健康的工作环境。 GSA 设施管理助理专员 Courtney Springer 阐述了他们的水质检测和修復策略。确保水系统的适当维护和测试对于最大限度地减少重金属和有利于细菌（包括军团菌）生长的条件的存在至关重要。这项工作对于大型建筑（例如许多 GSA 设施）以及具有装饰性喷泉或冷却水塔等独特功能的建筑尤其重要。

这导致对能够准确识别细菌的测试服务和解决方案的需求激增。随着监管审查的加强，军团菌检测市场持续成长，反映出人们为确保水质和降低退伍军人病爆发风险而做出的共同努力。

整个军团菌测试市场根据测试类型、应用、最终用户和地区进行分类。

从 2024 年到 2032 年，尿抗原检测领域将经历重大发展。尿液抗原检测因其方便和高效而成为首选诊断工具，推动了对检测服务和解决方案的需求。随着医疗保健提供者越来越依赖这种方法进行及时诊断和治疗，军团菌检测市场不断扩大，以满足对有效检测解决方案不断增长的需求。

从2024 年到2032 年，体外诊断测试领域的军团菌检测市场份额将实现显着的复合年增长率。 。体外诊断测试为医疗保健专业人员提供及时、可靠的结果，促进及时治疗和遏制工作。随着早期检测的重要性不断增加，对体外诊断测试解决方案的需求也在增加，从而推动了军团菌测试市场的扩张，以满足不断变化的医疗保健需求。

欧洲军团菌检测市场从2024 年到2032 年将呈现出值得称讚的复合年增长率。协议，包括医疗机构、商业建筑和工业场所。

对预防措施和早期检测的日益重视，刺激了整个地区对军团菌检测服务和产品的需求，推动了军团菌检测市场的成长。例如，2023年8月，波兰东南部城市热舒夫的供水中检测到军团菌后，波兰启动了一项调查。该国反情报机构 ABW 调查了故意污染的可能性，作为预防措施，热舒夫对其供水系统采取了消毒措施。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 肺炎和军团菌相关疾病的发生率上升
      • 军团菌检测的快速进展
      • 定期水质检测的严格规定
    • 产业陷阱与挑战
      • 与测试程序相关的高成本
      • 诊断测试的敏感度问题
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场估计与预测：按测试类型，2018 年 - 2032 年

  • 主要趋势
  • 培养方法
  • 尿抗原检测（UAT）
  • 血清学
  • 直接萤光抗体测试（DFA）
  • 聚合酶炼式反应 (PCR) 检测
  • 其他测试类型

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

  • 主要趋势
  • 水质检测
    • 微生物培养
    • DFA染色
    • 聚合酶炼式反应
  • 体外诊断 (IVD) 测试
    • 血液培养和痰液检查
    • 尿抗原测试
    • DFA染色
    • 聚合酶炼式反应
  • 其他应用

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 水处理厂
  • 诊断实验室
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • Abbott Laboratories
  • Becton, Dickinson & Company
  • Biomerieux
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • IDEXX Laboratories Inc
  • Merck KGaA
  • Pro-lab Diagnostics Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
简介目录
Product Code: 8361

Global Legionella Testing Market size will witness 8.6% CAGR between 2024 and 2032, driven by increasingly stringent water testing regulations enforced by regulatory bodies. With a significant rise in public health and safety concerns, authorities worldwide are imposing rigorous standards for Legionella detection in water systems.

For instance, in 2024, the General Services Administration (GSA) announced that it is conducting comprehensive water testing across numerous federal buildings to prioritize the health and safety of occupants and visitors. This proactive approach aids building managers in maintaining a healthy work environment. Courtney Springer, Assistant Commissioner for Facilities Management at GSA, shed light on their water testing and remediation strategies. Ensuring proper maintenance and testing of water systems is crucial to minimize the presence of heavy metals and conditions conducive to bacterial growth, including Legionella. This effort is particularly vital for large buildings, such as many GSA facilities, and those with unique features like decorative fountains or cooling towers.

This has led to a surge in demand for testing services and solutions capable of accurately identifying the bacteria. As regulatory scrutiny intensifies, the market for Legionella testing continues to grow, reflecting a concerted effort to ensure water quality and mitigate the risk of Legionnaires' disease outbreaks.

The overall Legionella Testing Market is classified based on the test type, application, end-user, and region.

The urinary antigen test segment will undergo significant development from 2024 to 2032. This approach offers a rapid and reliable means of detecting Legionella bacteria, particularly in cases of Legionnaires' disease. Urinary antigen testing has emerged as a preferred diagnostic tool for its convenience and efficiency, driving demand for testing services and solutions. As healthcare providers increasingly rely on this method for timely diagnosis and treatment, the Legionella Testing Market continues to expand to meet the growing need for effective testing solutions.

The legionella testing market share from the in vitro diagnostics testing segment will register a noteworthy CAGR from 2024 to 2032. These advanced diagnostic techniques offer accurate and efficient detection of Legionella bacteria crucial in preventing Legionnaires' disease outbreaks. In vitro diagnostics testing provides healthcare professionals with timely and reliable results, facilitating prompt treatment and containment efforts. As the importance of early detection grows, so does the demand for in vitro diagnostics testing solutions, fueling the expansion of the Legionella Testing Market to meet evolving healthcare needs.

Europe legionella testing market will showcase a commendable CAGR from 2024 to 2032. With a focus on public health and safety, European countries are increasingly implementing comprehensive testing protocols for water systems in various settings, including healthcare facilities, commercial buildings, and industrial sites.

This increased emphasis on preventive measures and early detection is fueling the demand for Legionella testing services and products across the region, driving growth in the Legionella Testing Market. For instance, in August 2023, an investigation was initiated in Poland after Legionella bacteria was detected in the water supply of Rzeszow, a city in the southeastern region. The country's counterintelligence agency, ABW, looked into the possibility of intentional contamination, and as a precautionary step, Rzeszow undertook disinfection measures for its water supply system.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of pneumonia and legionella related illnesses
      • 3.2.1.2 Rapid advancements in legionella testing
      • 3.2.1.3 Stringent regulations for regular water testing
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High costs associated with testing procedures
      • 3.2.2.2 Issues in sensitivity of diagnostic tests
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Culture methods
  • 5.3 Urinary antigen test (UAT)
  • 5.4 Serology
  • 5.5 Direct fluorescent antibody test (DFA)
  • 5.6 Polymerase chain reaction (PCR) testing
  • 5.7 Other test types

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Water testing
    • 6.2.1 Microbial culture
    • 6.2.2 DFA stain
    • 6.2.3 PCR
  • 6.3 Invitro diagnostics (IVD) testing
    • 6.3.1 Blood culture and sputum tests
    • 6.3.2 Urinary antigen tests
    • 6.3.3 DFA stain
    • 6.3.4 PCR
  • 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospital and clinics
  • 7.3 Water treatment plants
  • 7.4 Diagnostic laboratories
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Mexico
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Becton, Dickinson & Company
  • 9.3 Biomerieux
  • 9.4 Bio-Rad Laboratories Inc.
  • 9.5 Danaher Corporation
  • 9.6 IDEXX Laboratories Inc
  • 9.7 Merck KGaA
  • 9.8 Pro-lab Diagnostics Inc.
  • 9.9 QIAGEN N.V.
  • 9.10 Thermo Fisher Scientific Inc.